). This is reflected in the gradual decrease, down to 0.35, in the peak ratio seen in Figure  4 upon prolonged HC1 treatment.
No differences were seen between noradrenaline spectra obtained with quartz microscope slides or glass cover slips. and it remained stable up to 5 mm of treatment (Fig. 6) . The over-all mean peak ratio of the HC1treated dopamine fluonophore in the mast cells was 1.56 ± 0.03 (n = 21). This value is statistically higher (P < 0.001) than that found from the dopamine fluorophore in models (cf. recordings. Also, the nonadnenaline fluorophore in tissue
, showed a rapid disappearance of the 410-nm peak, and after 5-60 sec of HC1 treatment, Fig. 4 ). In the neutral state, the fully aromatic 6,7-dihydroxyisoquinoline, which is formed from the 1 noradnenaline fluorophore by acid (Fig.  1, VII) .0 (8), seems to have a slightly lower fluorescence yield than the nonadrenaline fluorophore in its neutral, quinoidal state (Fig.  1, VI) ( Table  I) .
SEC

Analysis
However, the noradrenaline fluonophore shows an increased fluorescence after 5 mm of HC1 treatment (Table  I) Table I ). It could be that the noradrenaline fluorophore is not fully converted into the fully aromatic state by the 5 mm of treatment (cf. Fig. 4 ) on that the used DHI preparation was not entirely pure. Figs. 4 and 6) . However, according to our previous experience
(1) the spectral shifts may be somewhat slower in certain _______ tissues.
mm.
It is noteworthy that a lower 370 :320-nm peak ratio was recorded from the dopamine fluorophore in the acid state when quartz microscope slides were used. This is probably caused by the treach- 2 and 3) . After the first step of the HC1 treatment, the dopamine fluorophore is characterized by a shift of the excitation peak from 410 to 370 nm, but this is not affected by the second HC1 treatment (Fig. 2) . The 370 :320-nm excitation peak ratio is between 1.1 and 1.8 (average about 1.5).
This ratio is rapidly reached, and it is stable throughout the prolonged HC1 treatment. The noradrenaline fluorophore is characterized by the following criteria: the peak in the excitation spectrum at 370 urn can sometimes be recorded after the first step of the HC1 treatment but rapidly diminishes upon the second treatment with a concomitant marked decrease in the fluorescence intensity; simultaneously, the peak at 320 nm is strongly increased (Fig.  3) , 
